All Comments by Takaomi Saido

  1. Generation of monoclonal antibody fragments binding the native γ-secretase complex for use in structural studies.
  2. α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies.
  3. Opposing effects of aging on large-scale brain systems for memory encoding and cognitive control.
  4. Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions.
  5. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.
  6. Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue.
  7. Quetiapine modulates conditioned anxiety and alternation behavior in Alzheimer's transgenic mice.
  8. Biomarker Positive and Negative Subjects in the ADNI Cohort: Clinical Characterization.
  9. Impact of Angiotensin Receptor Blockers on Alzheimer Disease Neuropathology in a Large Brain Autopsy Series.
  10. Activity dependent degeneration explains hub vulnerability in Alzheimer's disease.
  11. Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease.
  12. Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation.
  13. The Metalloprotease Meprin β Generates Amino Terminal-truncated Amyloid β Peptide Species.
  14. Microvascular cerebral blood volume changes in aging APP(swe)/PS1 (dE9) AD mouse model: a voxel-wise approach.
  15. Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood-Brain Barrier.